Syverson Strege & CO Organon & Co. Transaction History

Syverson Strege & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$21.42 - $32.08 $21 - $32	1 Added 1.49%	68 $1,000
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $2,121 - $2,606	67 New	67 $2,000
Q1 2022 Apr 13, 2022	SELL	$30.45 - $39.36 $2,009 - $2,597	-66 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$28.67 - $37.13 $28 - $37	1 Added 1.54%	66 $2,000
Q2 2021 Aug 04, 2021	BUY	$28.45 - $38.0 $1,849 - $2,470	65 New	65 $2,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Syverson Strege & CO, based on Form 13F filings with the SEC.

Stay updated on Syverson Strege & CO with notifications on news.